Loading…

1416 FALDAPREVIR PLUS PEGYLATED INTERFERON ALFA-2A AND RIBAVIRIN IN CHRONIC HCV GENOTYPE-1 TREATMENT-NAÏVE PATIENTS: FINAL RESULTS FROM STARTVERSO1, A RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE III TRIAL

Saved in:
Bibliographic Details
Published in:Journal of hepatology 2013-04, Vol.58, p.S569-S570
Main Authors: Ferenci, P, Asselah, T, Foster, G.R, Zeuzem, S, Sarrazin, C, Moreno, C, Ouzan, D, Maevskaya, M, Calinas, F, Morano, L.E, Crespo, J, Dufour, J.-F, Bourliere, M, Agarwal, K, Forton, D, Schuchmann, M, Zehnter, E, Nishiguchi, S, Omata, M, Stern, J.O, Datzenko, Y, Scherer, J, Quinson, A.-M
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0168-8278
1600-0641
DOI:10.1016/S0168-8278(13)61415-4